aristolochic acid i has been researched along with bardoxolone methyl in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, W; Fan, J; Feng, X; Liu, X; Wang, J; Wu, J; Yang, X; Yu, X; Zeng, Y | 1 |
| Ku, SK; Kwak, MK; Lee, JH; Lee, SH; Ryoo, IG; Song, MK | 1 |
2 other study(ies) available for aristolochic acid i and bardoxolone methyl
| Article | Year |
|---|---|
Bardoxolone methyl (BARD) ameliorates aristolochic acid (AA)-induced acute kidney injury through Nrf2 pathway.
Topics: Acute Kidney Injury; Animals; Aristolochic Acids; Cryoprotective Agents; Disease Models, Animal; Heme Oxygenase-1; Kidney; Male; Metabolic Networks and Pathways; Mice; Mice, Inbred C57BL; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; Oleanolic Acid | 2014 |
Bardoxolone ameliorates TGF-β1-associated renal fibrosis through Nrf2/Smad7 elevation.
Topics: Animals; Aristolochic Acids; Cell Line; Extracellular Matrix; Fibrosis; Gene Expression Regulation; Gene Knockdown Techniques; HEK293 Cells; Humans; Kelch-Like ECH-Associated Protein 1; Kidney Diseases; Male; Mesangial Cells; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Oleanolic Acid; RNA, Small Interfering; Signal Transduction; Smad7 Protein; Transforming Growth Factor beta1; Ubiquitin-Protein Ligases | 2019 |